Solutions
DIAMANTE provides targeted support across key areas of the healthcare ecosystem, addressing distinct challenges in drug development, diagnostics, investment strategy, and advanced manufacturing.
Our work is structured across four core verticals, each offering specialized expertise and dedicated capabilities:
Biopharma
DIAMANTE Biopharma vertical is led by Katharina Venturi and supports pharmaceutical and biotech organizations across the full drug development lifecycle — from discovery through clinical Proof of Concept and beyond.
More about our biopharma vertical
Our core areas of expertise include:
- Oncology
- Immuno-oncology and immunology (including vaccinology)
- Infectious diseases
- Cardiovascular diseases
- Respiratory and CNS conditions
- Rare disorders
- Medical devices
- Companion diagnostics across disease indications
- Biomarker-driven drug and target discovery and development
We operate across therapeutic modalities, focusing on target biology and biomarker-driven development. With our approach and deep understanding of the development and business process, we provide hands-on planning and execution for companies, creating the basis for successful funding and collaboration opportunities.
We offer a one-stop shop where our clients profit from clinical and regulatory development, scientific and technical consulting, as well as hands-on operational support in day-to-day project execution. We combine, together with DIAMANTE Healthcare Value vertical, a concomitant outreach to our investors and strategic network to accelerate value creation and growth for our partners.
Diagnostics
DIAMANTE Diagnostics vertical is led by Miro Venturi and supports the full diagnostics ecosystem — from in vitro diagnostics (IVDs) and laboratory-developed tests (LDTs) to central laboratories and emerging technology innovators.
More about our diagnostics vertical
We work with developers, suppliers, distributors, and early-stage technology companies across a broad range of diagnostic platforms and assay technologies.
While we operate across all diagnostic technologies and assay modalities, our focus lies in sequencing and molecular diagnostics, as well precision medicine and companion diagnostics in oncology, supporting implementation across the different stages of the patient journey.
Healthcare value
DIAMANTE Healthcare Value vertical, led by Miro Venturi, supports financial sponsors and fund providers in maximizing the quality and long-term performance of their healthcare investments.
More about our healthcare value vertical
Our approach drives strong value creation, efficient implementation, and sustainable technology adoption — ultimately generating measurable returns and meaningful patient impact within a broader healthcare ecosystem.
Our support spans the full investment lifecycle, including market landscaping and opportunity scouting, technical and strategic due diligence, M&A support, business execution and scaling strategies, as well as partnering and business development.
Biofoundry 2.0
DIAMANTE Biofoundry 2.0 vertical is led by Priyanka Dutta-Passecker and serves as a strategic partner in building scalable manufacturing platforms for regenerative therapeutics. We guide investors, VCs, biotech, and pharma companies through the complexities of advanced manufacturing for cell, gene, and stem‑cell therapies.
More about our biofoundry 2.0 vertical
We design tailored manufacturing strategies, optimize process development, enable tech transfer, and integrate GMP‑compliant quality systems – supporting activities from early research through commercialization.
With deep expertise in closed systems, digital manufacturing, and regulatory requirements, we future‑proof operations with scalable, automation‑ready, and cost‑effective solutions.
Our hands‑on, tech‑forward approach supports startups, CDMOs, and institutional manufacturers in translating promising therapies into commercially viable products, while providing investors with robust technical due diligence and risk assessment.